• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于儿童镰状细胞病队列研究中生物学参数的预后结果变异性:临床医生应该了解什么?

Variability of Prognostic Results Based on Biological Parameters in Sickle Cell Disease Cohort Studies in Children: What Should Clinicians Know?

作者信息

Sommet Julie, Roux Enora Le, Koehl Bérengère, Haouari Zinedine, Mohamed Damir, Baruchel André, Benkerrou Malika, Alberti Corinne

机构信息

AP-HP, Hôpital Robert-Debré, Unité d'épidémiologie clinique, Inserm, CIC 1426, 48 bd Serurier, F-75019 Paris, France.

Université de Paris, UMR 1123, ECEVE, 10 av de Verdun, F-75010 Paris, France.

出版信息

Children (Basel). 2021 Feb 13;8(2):143. doi: 10.3390/children8020143.

DOI:10.3390/children8020143
PMID:33668629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7917793/
Abstract

BACKGROUND

Many pediatric studies describe the association between biological parameters (BP) and severity of sickle cell disease (SCD) using different methods to collect or to analyze BP. This article assesses the methods used for collection and subsequent statistical analysis of BP, and how these impact prognostic results in SCD children cohort studies.

METHODS

Firstly, we identified the collection and statistical methods used in published SCD cohort studies. Secondly, these methods were applied to our cohort of 375 SCD children, to evaluate the association of BP with cerebral vasculopathy (CV).

RESULTS

In 16 cohort studies, BP were collected either once or several times during follow-up. The identified methods in the statistical analysis were: (1) one baseline value per patient (2) last known value; (3) mean of all values; (4) modelling of all values in a two-stage approach. Applying these four different statistical methods to our cohort, the results and interpretation of the association between BP and CV were different depending on the method used.

CONCLUSION

The BP prognostic value depends on the chosen statistical analysis method. Appropriate statistical analyses of prognostic factors in cohort studies should be considered and should enable valuable and reproducible conclusions.

摘要

背景

许多儿科研究使用不同的方法收集或分析生物学参数(BP),描述了生物学参数与镰状细胞病(SCD)严重程度之间的关联。本文评估了用于收集BP以及对其进行后续统计分析的方法,以及这些方法如何影响SCD儿童队列研究的预后结果。

方法

首先,我们确定已发表的SCD队列研究中使用的收集和统计方法。其次,将这些方法应用于我们的375名SCD儿童队列,以评估BP与脑血管病变(CV)的关联。

结果

在16项队列研究中,在随访期间收集BP一次或多次。统计分析中确定的方法有:(1)每位患者一个基线值;(2)最后已知值;(3)所有值的平均值;(4)分两阶段对所有值进行建模。将这四种不同的统计方法应用于我们的队列,BP与CV之间关联的结果和解释因所用方法而异。

结论

BP的预后价值取决于所选的统计分析方法。队列研究中应考虑对预后因素进行适当的统计分析,这应能得出有价值且可重复的结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a626/7917793/f02ad5f89d4a/children-08-00143-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a626/7917793/f02ad5f89d4a/children-08-00143-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a626/7917793/f02ad5f89d4a/children-08-00143-g001.jpg

相似文献

1
Variability of Prognostic Results Based on Biological Parameters in Sickle Cell Disease Cohort Studies in Children: What Should Clinicians Know?基于儿童镰状细胞病队列研究中生物学参数的预后结果变异性:临床医生应该了解什么?
Children (Basel). 2021 Feb 13;8(2):143. doi: 10.3390/children8020143.
2
3
Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study.镰状细胞病新生儿队列中脑大血管病变的临床和血液学危险因素:一项前瞻性研究
Br J Haematol. 2016 Mar;172(6):966-77. doi: 10.1111/bjh.13916. Epub 2016 Jan 5.
4
Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.镰状细胞临床研究和干预计划 (SCCRIP):一项从儿科阶段到成年期镰状细胞病进展的寿命队列研究。
Pediatr Blood Cancer. 2018 Sep;65(9):e27228. doi: 10.1002/pbc.27228. Epub 2018 May 24.
5
Decreased heart rate variability is associated with increased transcranial Doppler velocities in children with sickle cell disease.镰状细胞病患儿心率变异性降低与经颅多普勒速度增加有关。
Ethn Dis. 2014 Autumn;24(4):451-5.
6
Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy.镰状细胞病和严重脑血管病变患儿脑血管重建手术后明显和隐匿性卒中复发率的降低
Pediatr Blood Cancer. 2016 Aug;63(8):1431-7. doi: 10.1002/pbc.26022. Epub 2016 Apr 22.
7
Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.德国西南部镰状细胞病的显著流行:一项出生队列研究结果表明新生儿筛查的必要性。
Ann Hematol. 2016 Feb;95(3):397-402. doi: 10.1007/s00277-015-2573-y. Epub 2015 Dec 12.
8
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: an Italian cohort study.儿童和青少年镰状细胞病的内分泌和代谢并发症:一项意大利队列研究。
BMC Pediatr. 2019 Feb 11;19(1):56. doi: 10.1186/s12887-019-1423-9.
9
Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease.估算患有镰状细胞病与不患有镰状细胞病患者的预期寿命和收入。
JAMA Netw Open. 2019 Nov 1;2(11):e1915374. doi: 10.1001/jamanetworkopen.2019.15374.
10
Blood pressure in acute vaso-occlusive crises of sickle cell disease.镰状细胞病急性血管闭塞性危象时的血压
South Med J. 2000 Jun;93(6):590-2.

本文引用的文献

1
A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.羟基脲治疗期间镰状细胞贫血患儿具有临床意义的胎儿血红蛋白阈值。
Am J Hematol. 2017 Dec;92(12):1333-1339. doi: 10.1002/ajh.24906. Epub 2017 Sep 28.
2
Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe.镰状细胞病成年患者死亡的危险因素:北美和欧洲研究的荟萃分析
Haematologica. 2017 Apr;102(4):626-636. doi: 10.3324/haematol.2016.153791. Epub 2017 Jan 19.
3
Longitudinal Analysis of Patient Specific Predictors for Mortality in Sickle Cell Disease.
镰状细胞病患者死亡率的个体特异性预测因素的纵向分析。
PLoS One. 2016 Oct 20;11(10):e0164743. doi: 10.1371/journal.pone.0164743. eCollection 2016.
4
Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study.镰状细胞病新生儿队列中脑大血管病变的临床和血液学危险因素:一项前瞻性研究
Br J Haematol. 2016 Mar;172(6):966-77. doi: 10.1111/bjh.13916. Epub 2016 Jan 5.
5
Early Reticulocytosis and Anemia Are Associated with Abnormal and Conditional Transcranial Doppler Velocities in Children with Sickle Cell Anemia.早期网织红细胞增多和贫血与镰状细胞贫血患儿经颅多普勒异常及条件性速度有关。
J Pediatr. 2016 Feb;169:227-31.e1. doi: 10.1016/j.jpeds.2015.10.031. Epub 2015 Nov 17.
6
Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial.羟基脲预防镰状细胞贫血患者经颅多普勒异常转变:一项III期国际随机临床试验
Am J Hematol. 2015 Dec;90(12):1099-105. doi: 10.1002/ajh.24198. Epub 2015 Nov 17.
7
Increasing value and reducing waste in research design, conduct, and analysis.提高研究设计、实施和分析的价值并减少浪费。
Lancet. 2014 Jan 11;383(9912):166-75. doi: 10.1016/S0140-6736(13)62227-8. Epub 2014 Jan 8.
8
Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach.采用联合建模方法研究吗替麦考酚酸的纵向暴露对肾移植受者急性排斥反应的影响。
Pharmacol Res. 2013 Jun;72:52-60. doi: 10.1016/j.phrs.2013.03.009. Epub 2013 Apr 1.
9
An introduction to mixed models and joint modeling: analysis of valve function over time.混合模型和联合建模简介:随时间变化的瓣膜功能分析。
Ann Thorac Surg. 2012 Jun;93(6):1765-72. doi: 10.1016/j.athoracsur.2012.02.049.
10
Biomarkers in sickle cell disease.镰状细胞病的生物标志物。
Br J Haematol. 2012 Feb;156(4):433-45. doi: 10.1111/j.1365-2141.2011.08961.x. Epub 2011 Nov 28.